Cargando…
Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study
BACKGROUND: Renin-angiotensin-aldosterone system (RAAS) inhibitors may facilitate host cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or attenuate organ injury via RAAS blockade. We aimed to assess the associations between prior use of RAAS inhibitors and clinical outcome...
Autores principales: | Jung, Sun-Young, Choi, Jae Chol, You, Seung-Hun, Kim, Won-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314113/ https://www.ncbi.nlm.nih.gov/pubmed/32442285 http://dx.doi.org/10.1093/cid/ciaa624 |
Ejemplares similares
-
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021) -
Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea
por: Park, Jungchan, et al.
Publicado: (2021) -
Update on association between exposure to renin-angiotensin-aldosterone system inhibitors and coronavirus disease 2019 in South Korea
por: Seo, Jeongkuk, et al.
Publicado: (2021) -
Renin-angiotensin-aldosterone system and kidney interactions in heart
failure
por: Ferreira, João Pedro, et al.
Publicado: (2019) -
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)